ORLANDO, Fla. — Steering clinicians toward a cascade approach for thyroid function testing cut unnecessary orders by a monthly average of 15% and concurrent orders by 19% per month, according to ...
Dual immune checkpoint inhibition with nivolumab and ipilimumab (N+I) in patients with advanced anaplastic thyroid carcinoma (ATC). PEMDA-HN, an open-label, phase II, randomized controlled study of ...
TAZNI: A phase I/II combination trial of tazemetostat with nivolumab and ipilimumab for children with INI1-negative or SMARCA4-deficient tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results